JP2022535708A5 - - Google Patents
Info
- Publication number
- JP2022535708A5 JP2022535708A5 JP2021569341A JP2021569341A JP2022535708A5 JP 2022535708 A5 JP2022535708 A5 JP 2022535708A5 JP 2021569341 A JP2021569341 A JP 2021569341A JP 2021569341 A JP2021569341 A JP 2021569341A JP 2022535708 A5 JP2022535708 A5 JP 2022535708A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024223651A JP2025041739A (ja) | 2019-05-24 | 2024-12-19 | 核酸、薬物組成物及び複合体ならびに調製方法と使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910440575 | 2019-05-24 | ||
| CN201910440575.8 | 2019-05-24 | ||
| PCT/CN2020/091624 WO2020238763A1 (zh) | 2019-05-24 | 2020-05-21 | 核酸、药物组合物与缀合物及制备方法和用途 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024223651A Division JP2025041739A (ja) | 2019-05-24 | 2024-12-19 | 核酸、薬物組成物及び複合体ならびに調製方法と使用 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022535708A JP2022535708A (ja) | 2022-08-10 |
| JP2022535708A5 true JP2022535708A5 (https=) | 2023-05-29 |
| JPWO2020238763A5 JPWO2020238763A5 (https=) | 2023-05-29 |
| JP7613751B2 JP7613751B2 (ja) | 2025-01-15 |
Family
ID=73553779
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021569341A Active JP7613751B2 (ja) | 2019-05-24 | 2020-05-21 | 核酸、薬物組成物及び複合体ならびに調製方法と使用 |
| JP2024223651A Pending JP2025041739A (ja) | 2019-05-24 | 2024-12-19 | 核酸、薬物組成物及び複合体ならびに調製方法と使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024223651A Pending JP2025041739A (ja) | 2019-05-24 | 2024-12-19 | 核酸、薬物組成物及び複合体ならびに調製方法と使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220186221A1 (https=) |
| EP (1) | EP3978029A4 (https=) |
| JP (2) | JP7613751B2 (https=) |
| KR (1) | KR20220012284A (https=) |
| CN (2) | CN118217305A (https=) |
| AU (1) | AU2020282453A1 (https=) |
| CA (1) | CA3140233A1 (https=) |
| WO (1) | WO2020238763A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3083968C (en) | 2017-12-01 | 2024-04-23 | Suzhou Ribo Life Science Co., Ltd. | Double-stranded oligonucleotide, composition and conjugate comprising double-stranded oligonucleotide, preparation method thereof and use thereof |
| WO2019105435A1 (zh) | 2017-12-01 | 2019-06-06 | 苏州瑞博生物技术有限公司 | 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途 |
| JP7365052B2 (ja) | 2017-12-01 | 2023-10-19 | スーチョウ リボ ライフ サイエンス カンパニー、リミテッド | 核酸、当該核酸を含む組成物及び複合体ならびに調製方法と使用 |
| CN110945130B (zh) | 2017-12-01 | 2024-04-09 | 苏州瑞博生物技术股份有限公司 | 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途 |
| US11918600B2 (en) | 2018-08-21 | 2024-03-05 | Suzhou Ribo Life Science Co., Ltd. | Nucleic acid, pharmaceutical composition and conjugate containing nucleic acid, and use thereof |
| EP3862024A4 (en) | 2018-09-30 | 2022-08-17 | Suzhou Ribo Life Science Co., Ltd. | SIRNA CONJUGATE, METHOD FOR ITS PRODUCTION AND ITS USE |
| US12496347B2 (en) | 2018-12-28 | 2025-12-16 | Suzhou Ribo Life Science Co., Ltd. | Nucleic acid, composition and conjugate containing nucleic acid, preparation method therefor and use thereof |
| AU2020280438B2 (en) * | 2019-05-22 | 2025-03-06 | Suzhou Ribo Life Science Co., Ltd. | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use |
| JP7610268B2 (ja) | 2019-05-22 | 2025-01-08 | スーチョウ リボ ライフ サイエンス カンパニー、リミテッド | 核酸、薬物組成物及び複合体ならびに調製方法と使用 |
| WO2020233680A1 (zh) | 2019-05-22 | 2020-11-26 | 苏州瑞博生物技术股份有限公司 | 核酸、药物组合物与缀合物及制备方法和用途 |
| EP3978609A4 (en) | 2019-05-24 | 2024-02-07 | Suzhou Ribo Life Science Co., Ltd. | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use |
| CN115028670B (zh) * | 2022-06-24 | 2023-07-28 | 四川大学华西医院 | 一种n-乙酰基-d-半乳糖胺三聚体前体的制备方法 |
| CN118773195A (zh) * | 2023-06-16 | 2024-10-15 | 施能康医药科技(苏州)有限公司 | 靶向补体成分5的核酸及其用途 |
| WO2025026124A1 (zh) * | 2023-08-03 | 2025-02-06 | 苏州炫景生物科技有限公司 | C4b基因抑制剂组合物及其应用 |
| CN119585432B (zh) * | 2023-08-22 | 2025-08-12 | 成都先衍生物技术有限公司 | 一种靶向AGT基因表达的siRNA及其缀合物和用途 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009082607A2 (en) | 2007-12-04 | 2009-07-02 | Alnylam Pharmaceuticals, Inc. | Targeting lipids |
| US20120136073A1 (en) | 2010-11-15 | 2012-05-31 | Life Technologies Corporation | Amine-Containing Transfection Reagents and methods for making and using same |
| AU2013299717B2 (en) | 2012-08-06 | 2018-06-28 | Alnylam Pharmaceuticals, Inc. | Carbohydrate conjugated RNA agents and process for their preparation |
| CA3216595A1 (en) * | 2013-03-14 | 2014-10-02 | Kevin Fitzgerald | Complement component c5 irna compositions and methods of use thereof |
| DK2991656T3 (da) | 2013-05-01 | 2020-03-23 | Ionis Pharmaceuticals Inc | Sammensætninger og fremgangsmåder til modulering af apolipoprotein c-iii-ekspression |
| JP6702862B2 (ja) | 2013-07-11 | 2020-06-03 | アルニラム ファーマスーティカルズ インコーポレイテッドＡｌｎｙｌａｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | オリゴヌクレオチド−リガンドコンジュゲートおよびそれらの調製方法 |
| JP2017522046A (ja) * | 2014-06-06 | 2017-08-10 | ソルスティス バイオロジクス，リミティッド | 生物可逆的および生物不可逆的基を有するポリヌクレオチド構築物 |
| IL316808A (en) * | 2014-08-20 | 2025-01-01 | Alnylam Pharmaceuticals Inc | Modified double-stranded RNA materials and their uses |
| EP3191591A1 (en) | 2014-09-12 | 2017-07-19 | Alnylam Pharmaceuticals, Inc. | Polynucleotide agents targeting complement component c5 and methods of use thereof |
| US10036017B2 (en) * | 2015-02-17 | 2018-07-31 | Dicerna Pharmaceuticals, Inc. | Methods and compositions for the specific inhibition of complement component 5(C5) by double-stranded RNA |
| EP4365291A3 (en) | 2015-06-12 | 2024-08-14 | Alnylam Pharmaceuticals, Inc. | Complement component c5 irna compositions and methods of use thereof |
| WO2019105435A1 (zh) * | 2017-12-01 | 2019-06-06 | 苏州瑞博生物技术有限公司 | 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途 |
| WO2019105437A1 (zh) * | 2017-12-01 | 2019-06-06 | 苏州瑞博生物技术有限公司 | 一种核酸、含有该核酸的组合物与缀合物及制备方法和用途 |
| EP3732185B1 (en) * | 2017-12-29 | 2025-02-26 | Suzhou Ribo Life Science Co., Ltd. | Conjugates and preparation and use thereof |
| AU2020280438B2 (en) * | 2019-05-22 | 2025-03-06 | Suzhou Ribo Life Science Co., Ltd. | Nucleic acid, pharmaceutical composition, conjugate, preparation method, and use |
-
2020
- 2020-05-21 CA CA3140233A patent/CA3140233A1/en active Pending
- 2020-05-21 JP JP2021569341A patent/JP7613751B2/ja active Active
- 2020-05-21 CN CN202410300945.9A patent/CN118217305A/zh active Pending
- 2020-05-21 CN CN202080033909.0A patent/CN113795280B/zh active Active
- 2020-05-21 WO PCT/CN2020/091624 patent/WO2020238763A1/zh not_active Ceased
- 2020-05-21 US US17/595,577 patent/US20220186221A1/en active Pending
- 2020-05-21 EP EP20814338.8A patent/EP3978029A4/en active Pending
- 2020-05-21 KR KR1020217041240A patent/KR20220012284A/ko active Pending
- 2020-05-21 AU AU2020282453A patent/AU2020282453A1/en active Pending
-
2024
- 2024-12-19 JP JP2024223651A patent/JP2025041739A/ja active Pending